Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2025-12-25 @ 4:53 PM
NCT ID:
NCT02851303
Group ID:
EG000
Title:
Morphine
Description:
Dose given q 3 - 4 hrs with feeds; do not exceed 4 hrs between doses Morphine (0.04mg/0.1ml)
Score Dose For Initiation 0-8 0 None 9-12 0.04 mg/dose 13-16 0.08 mg/dose 17-20 0.12 mg/dose 21-24 0.16 mg/dose 25 or above 0.20mg/dose
Morphine Maintenance/Escalation
* Maintain dose if score 0-8
* Increase dose by 0.02 if score is 9-12 (rescore before dosing) • Increase dose by 0.04 if score 13-16
* Increase score by 0.06 if score 17-20
Weaning Instructions:
* Maintain on dose 48 hrs before starting weaning
* Wean 0.02 mg morphine every day for a score is 0-8 • Defer wean for score 9-12
Re-escalation
* If neonate scores 9-12 re-score as described for initiation,
* If second score is in 9-12 increase morphine 0.01 mg q3-4 hrs • If 2 consecutive scores 13-16, increase 0.02 mg q3-4 hrs
* If 2 consecutive scores in 17-20, increase 0.04 mg q3-4 hrs etc
Morphine: Morphine wean protocol as described in arm description
Adverse events were recorded only for infants of each dyad.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
15
Other Number Affected:
0
Other Number At Risk:
15
Study:
NCT02851303
Results Section:
NCT02851303
Adverse Events Module:
NCT02851303